Dopamine D2 receptor antagonist sulpiride enhances dexamethasone responses in the treatment of drug-resistant and metastatic breast cancer

Lignende værker

• Preclinical PK/PD model for the combinatorial use of dexamethasone and sulpiride in the treatment of breast cancer
  af: Yao, Qing-yu, et al.
  Udgivet: (2019)
• Time-dependent pharmacokinetics of dexamethasone and its efficacy in human breast cancer xenograft mice: a semi-mechanism-based pharmacokinetic/pharmacodynamic model
  af: Li, Jian, et al.
  Udgivet: (2018)
• The dopamine D2 receptor antagonist sulpiride modulates striatal BOLD signal during the manipulation of information in working memory
  af: Dodds, Chris M., et al.
  Udgivet: (2009)
• A low dosage of the dopamine D2-receptor antagonist sulpiride affects effort allocation for reward regardless of trait extraversion
  af: Ohmann, Hanno Andreas, et al.
  Udgivet: (2020)
• Roles of dopamine receptors and their antagonist thioridazine in hepatoma metastasis
  af: Lu, Meiling, et al.
  Udgivet: (2015)